MDWD — MediWound Ltd.

Nasdaq · Materials · Chemicals · CIK 1593984 ·
Last close
$14.20
Market Cap
$182.50M
52W High
$18.13
52W Low
$13.54
ADV30
99,653
Next earnings
2026-08-13
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 1,475,000 323,000 -7,980,000 -2,952,000 79,982,000 38,559,000
Dec 2025 1,867,000 278,000 -7,813,000 -7,183,000 86,255,000 4,799,000 42,623,000
Sep 2025 5,429,000 896,000 -6,525,000 -2,652,000 94,423,000 44,267,000
Jun 2025 5,708,000 1,342,000 -5,716,000 -13,318,000 67,001,000 46,882,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-16,121,000
Investing CF
$-17,950,000
Financing CF
$29,620,000
CapEx
$-5,505,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-2.10
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-228,925,000
Inventory
$4,093,000
Receivables
$2,372,000
ST Investments
$48,341,000
EBIT TTM
$-23,330,000
Pretax Income TTM
$-23,710,000
Interest Exp TTM
$7,564,000
Analysts
6

Yahoo Snapshot (yfinance, live)

Total Revenue
$14,479,000
EBITDA
$-27,015,000
Free Cash Flow
$-18,442,750
Enterprise Value
$142,043,232
Total Cash
$44,646,000
Total Debt
$8,126,000
Shares Out
12,852,255
Trailing EPS
$-2.26
Book Value
$3.22
ROE
-71.8%
ROA
-23.5%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 16,959,000 -25,279,000 -23,879,000 86,255,000 42,623,000 -16,121,000
Dec 2024 20,222,000 -19,382,000 -30,224,000 73,496,000 42,343,000 -13,624,000
Dec 2023 18,686,000 -15,501,000 -6,716,000 66,459,000 34,864,000 -10,465,000
Dec 2022 26,496,000 -7,661,000 -19,599,000 50,016,000 39,102,000 -11,885,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-2.22

Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $14.00 · spot: $14.20 · call volume: 221 · put volume: 40
Expected Move to 2026-09-18: ±$2.81 (19.79%) — implied range $11.39$17.01 · ATM straddle on $14.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ACB AURORA CANNABIS INC $180.87M $2.92
FF FutureFuel Corp. $185.54M $4.23
WALD Waldencast plc $196.28M $1.66
LQMT LIQUIDMETAL TECHNOLOGIES INC $166.03M $0.18
ZONE CleanCore Solutions, Inc. $202.52M $0.91

News headlines (Yahoo Finance, 1h cache)

Will MediWound (NASDAQ:MDWD) Spend Its Cash Wisely?
2026-05-28 12:53 · Yahoo
MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue ...
2026-05-27 21:00 · Yahoo
MediWound (MDWD) Q1 2026 Earnings Transcript
2026-05-27 18:34 · Yahoo
MediWound Q1 Earnings Call Highlights
2026-05-27 14:06 · Yahoo
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates
2026-05-27 12:10 · Yahoo
NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates
2026-05-15 21:55 · Yahoo
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates
2026-05-14 23:40 · Yahoo
Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates
2026-05-13 21:15 · Yahoo
Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates
2026-05-07 21:55 · Yahoo
MediWound to Report First Quarter 2026 Financial Results
2026-05-07 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.